Last updated: August 14, 2026

Application No. 18/577,856

NEW SELECTIVE ANGIOTENSIN II COMPOUNDS

Final Rejection

Filed

Jan 09, 2024

Priority

Jul 09, 2021 — GB 2109946.0 +2 more

Examiner

MCDOWELL, BRIAN E

Art Unit

1624

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

VICORE PHARMA AB

OA Round

4 (Final)

Interview Optional

— +30.4% interview lift. Examiner has a relatively high allowance rate (74%); +30.4% interview lift. A written response may suffice.

Based on 1125 resolved cases, 2023–2026

Examiner Intelligence

MCDOWELL, BRIAN E View full profile →

Grants 74% — above average

Career Allowance Rate

835 granted / 1125 resolved

+14.2% vs TC avg

Strong +30% interview lift

Without

With

+30.4%

Interview Lift

resolved cases with interview

Typical timeline

2y 2m

Avg Prosecution

75 currently pending

Career history

1178

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

16.5%

-23.5% vs TC avg

§102

20.3%

-19.7% vs TC avg

§112

49.8%

+9.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1125 resolved cases

Prosecution Timeline

Show 4 earlier events

Aug 19, 2025

Response Filed

Oct 09, 2025

Final Rejection mailed

Jan 09, 2026

Response after Non-Final Action

Jan 29, 2026

Request for Continued Examination

Feb 02, 2026

Response after Non-Final Action

Mar 27, 2026

Non-Final Rejection mailed

Jun 29, 2026

Response Filed

Jul 30, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/905,791

Patent 12703694

PYRAZOLE CARBOXYLATE ESTER COMPOUND AND USE THEREOF

3y 11m to grant Granted Aug 11, 2026

18/003,758

Patent 12698283

QUINOLINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS, AND METHODS OF USE THEREOF

3y 7m to grant Granted Aug 04, 2026

17/883,933

Patent 12691129

USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES

3y 11m to grant Granted Jul 28, 2026

18/323,939

Patent 12673920

INHIBITORS OF NLRP3 INFLAMMASOME

3y 1m to grant Granted Jul 07, 2026

17/629,344

Patent 12667101

PICOLINAMIDE DERIVATIVES USEFUL AS AGRICULTURAL FUNGICIDES

4y 5m to grant Granted Jun 30, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6

Expected OA Rounds

74%

Grant Probability

99%

With Interview (+30.4%)

2y 2m (~0m remaining)

Median Time to Grant

High

PTA Risk

Based on 1125 resolved cases by this examiner. Grant probability derived from career allowance rate.